1. Home
  2. HLX vs PGEN Comparison

HLX vs PGEN Comparison

Compare HLX & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$8.64

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.76

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
PGEN
Founded
1979
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
HLX
PGEN
Price
$8.64
$4.76
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$11.50
$8.33
AVG Volume (30 Days)
1.3M
4.9M
Earning Date
04-22-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$876,561,000.00
$230,981,000.00
Revenue This Year
$2.05
$1,115.92
Revenue Next Year
$5.46
$81.04
P/E Ratio
N/A
N/A
Revenue Growth
3.60
N/A
52 Week Low
$5.52
$1.40
52 Week High
$10.75
$5.47

Technical Indicators

Market Signals
Indicator
HLX
PGEN
Relative Strength Index (RSI) 34.57 64.27
Support Level $8.58 $3.96
Resistance Level $10.54 $5.06
Average True Range (ATR) 0.34 0.29
MACD -0.09 0.10
Stochastic Oscillator 14.08 94.24

Price Performance

Historical Comparison
HLX
PGEN

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: